Samsung Biologics Co. said it plans to carve its business into a contract drug manufacturer and a holding firm which will ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...

The president announced last week that his administration would be instituting a “most favored nation” policy that would peg ...

Gulf South Angels, a New Orleans-based investment network, is investing in non-opioid pain drug startup South Rampart Pharma, ...

Having posted record annual revenue of $NZ208 million, AFT Pharmaceuticals says it can achieve further 50% growth over the ...

One of Mission’s largest employers announced mass layoffs in the company, citing financial concerns and a “challenging environment.” ...

AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in ...

As part of a broader resurgence in pharmaceutical pricing reform and manufacturing policies in 2025, President Donald Trump ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

Squeezed by insurers and middlemen, independent pharmacists find themselves on the front lines of a tariff storm.

Experts said Trump’s action could lower the cost of prescription drugs, but they cautioned it's far from an immediate fix.